Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Streptomyces hyaluronidase is a highly specific hyaluronate lyase enzyme derived from the bacterium *Streptomyces hyalurolyticus*. It functions by cleaving the beta-1,4-glycosidic linkages of hyaluronan (hyaluronic acid), a major component of the extracellular matrix, resulting in the formation of unsaturated oligosaccharides. Unlike animal-derived testicular hyaluronidases, the *Streptomyces* variant is highly selective for hyaluronan and does not degrade other glycosaminoglycans such as chondroitin sulfate or dermatan sulfate. In research settings, it is frequently employed as a high-purity laboratory tool to study the role of the pericellular hyaluronan coat and its degradation products (HA fragments) in biological processes. Specifically, it is used to investigate how HA fragmentation mediates inflammatory signaling pathways, such as p38-NFkβ, and contributes to tumor formation in models of melanomagenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on streptomyces hyaluronidase.